ARCHIVES

FDA Nearly Wrecks NCI Drug Distribution Program, Finally Agrees To New Guidelines

This article is from The Cancer Letter archive.

Vol. 02 No. 05 | January 30, 1976

Download PDF Visit The Full Archive

Related Articles

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

July 27, 2001

FDA News: FDA Lifts Clinical Hold On CTI’s Tosedostat

January 31, 2014

Radio Host, Physician Elmer Huerta Becomes American Cancer Society President.

November 9, 2007

DCT Will Consider Planning, Center Core Supplemental, Program Project Grants In $5 Million Surgical Oncology Development Effort

October 10, 1980

Six Compounds Carcinogenic, Risk to Humans, CH Subgroup Finds

February 2, 1979

In Brief: NIDDK Begins BPH Trial; Roswell Park Honors Schwarzkopf; NRC Cites MIT

March 1, 1996